Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP14 | P50281 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | ACP3 | P15309 | 2/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18372118 | 0.98 | NPSR1 (0.36) | NPSR1LMNAACP3 | |
| SCHEMBL18372103 | 0.95 | NPSR1 (0.41) | NPSR1LMNAKMT2A | |
| SCHEMBL18372136 | 0.92 | LMNA (0.40) | NPSR1LMNAMEN1KMT2AMMP8 | |
| SCHEMBL18372115 | 0.92 | LMNA (0.40) | NPSR1LMNAMEN1KMT2AMMP8 | |
| SCHEMBL18372163 | 0.92 | LMNA (0.40) | NPSR1LMNAMEN1KMT2AMMP8 | |
| SCHEMBL18372111 | 0.88 | TOP1 (0.36) | NPSR1LMNAKMT2ATOP1 | |
| SCHEMBL18372130 | 0.88 | NPSR1 (0.40) | NPSR1LMNA | |
| SCHEMBL18372082 | 0.85 | KIF11 (0.40) | ACP3 | |
| SCHEMBL18372140 | 0.83 | ESR1 (0.34) | — | |
| SCHEMBL18372109 | 0.82 | ESR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | PIEZO1, TERT, TPR | NPSR1 4592/4885LMNA 2224/4885MEN1 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.